chr13-112690441-C-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_015205.3(ATP11A):āc.25C>Gā(p.Leu9Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000497 in 1,206,298 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015205.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP11A | NM_015205.3 | c.25C>G | p.Leu9Val | missense_variant | 1/30 | ENST00000375645.8 | NP_056020.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP11A | ENST00000375645.8 | c.25C>G | p.Leu9Val | missense_variant | 1/30 | 5 | NM_015205.3 | ENSP00000364796 | P1 | |
ATP11A | ENST00000375630.6 | c.25C>G | p.Leu9Val | missense_variant | 1/29 | 5 | ENSP00000364781 | |||
ATP11A | ENST00000487903.5 | c.25C>G | p.Leu9Val | missense_variant | 1/30 | 5 | ENSP00000420387 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000497 AC: 6AN: 1206298Hom.: 0 Cov.: 30 AF XY: 0.00000339 AC XY: 2AN XY: 589260
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 10, 2023 | The c.25C>G (p.L9V) alteration is located in exon 1 (coding exon 1) of the ATP11A gene. This alteration results from a C to G substitution at nucleotide position 25, causing the leucine (L) at amino acid position 9 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at